Literature DB >> 6427017

Luteal phase serum estradiol and progesterone in in vitro fertilization.

S Muasher, A A Acosta, J E Garcia, G S Jones, H W Jones.   

Abstract

One hundred seventy-five cycles in patients with irreparable tubal disease were stimulated by human menopausal gonadotropin/human chorionic gonadotropin for the purpose of in vitro fertilization. The pregnancy rate was found to be related to the height and pattern of serum estradiol (E2) response in the follicular phase. The mean serum E2 and progesterone (P) during the luteal phase showed no statistically significant difference between the pregnant and nonpregnant patients in the series except after luteal day 11. The mean serum E2 in most of the luteal phase days was highest in the high responders followed by the normal and the low responders. However, the mean P values were similar for the high and normal responders but higher than the low responders on cycle days 18, 20, and 22. The mean serum E2 and P in the luteal phase showed no statistically significant difference among the three most common patterns. This was also true for the pregnant and nonpregnant values in each category of height and pattern of response. We concluded that the success and failure of in vitro fertilization was probably less related to the peripheral E2 and P in the luteal phase than to the number and quality of eggs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427017     DOI: 10.1016/s0015-0282(16)47895-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Preovulatory serum gonadotropin levels in hMG stimulated menstrual cycles in pregnant and nonpregnant patients.

Authors:  J F van Uem; A A Acosta; J E Garcia; Z Rosenwaks
Journal:  Arch Gynecol       Date:  1987

2.  Modifying effects of epidural analgesia or general anesthesia on the stress hormone response to laparoscopy for in vitro fertilization.

Authors:  A M Lehtinen; T Laatikainen; A I Koskimies; J Hovorka
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-02

3.  Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme.

Authors:  E M Smith; F W Anthony; S C Gadd; G M Masson
Journal:  BMJ       Date:  1989-06-03

4.  Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles.

Authors:  Akihisa Fujimoto; Yutaka Osuga; Toshihiro Fujiwara; Tetsu Yano; Osamu Tsutsumi; Mikio Momoeda; Koji Kugu; Kaori Koga; Yutaka Morita; Osamu Wada; Yuji Taketani
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.